Myasthenia gravis seronegative for acetylcholine receptor antibodies

Annals of the New York Academy of Sciences

Volumn 1132, Issue , 2008, Pages 84-92

  Vincent, Angela ^a,b   Leite, Maria Isabel ^a   Farrugia, Maria Elena ^a   Jacob, Saiju ^a   Viegas, Stuart ^a   Shiraishi, Hiro ^a   Benveniste, Olivier ^a   Morgan, B Paul ^a   Hilton Jones, David ^a   Newsom Davis, John ^a   Beeson, David ^a   Willcox, Nick ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acetylcholine receptor; Animal model; Complement; IgG subclass; Immunoglobulin G; Muscle specific kinase; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; COMPLEMENT COMPONENT C3B; CORTICOSTEROID; IMMUNOGLOBULIN G; PHOSPHOTRANSFERASE;

AUTOIMMUNITY; CELL CULTURE; CELL LINE; CONFERENCE PAPER; ELECTROPHYSIOLOGY; ENDPLATE POTENTIAL; FACE MUSCLE; HUMAN; LEG MUSCLE; MUSCLE ATROPHY; MUSCLE CELL; MYASTHENIA GRAVIS; MYOTUBE; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PATHOGENICITY; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; STATISTICAL SIGNIFICANCE; THYMECTOMY;

ANIMALIA;

EID: 45249113530     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1405.020     Document Type: Conference Paper

References (37)

1. Shiraishi, H., M. Motomura, T. Yoshimura, et al. 2005. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol. 57 : 289 293.
2. Lee, J.Y., J.J. Sung, J.Y. Cho, et al. 2006. MuSK antibody-positive, seronegative myasthenia gravis in Korea. J. Clin. Neurosci. 13 : 353 355.
3. Zhang, X., M. Yang, J. Xu, et al. 2007. Clinical and serological study of myasthenia gravis in HuBei Province, China. J. Neurol. Neurosurg. Psychiatry 78 : 386 390.
4. Sanders, D.B., K. El-Salem, J.M. Massey, et al. 2003. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60 : 1978 1980.
5. Stickler, D.E., J.M. Massey & D.B. Sanders. 2005. MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns. Clin. Neurophysiol. 116 : 2065 2068.
6. Oh, S.J., Y. Hatanaka, S. Hemmi, et al. 2006. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis. Muscle Nerve 33 : 500 504.
7. Evoli, A., P.A. Tonali, L. Padua, et al. 2003. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126 : 2304 2311.
8. Zhou, L., J. McConville, V. Chaudhry, et al. 2004. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. Muscle Nerve 30 : 55 60.
9. Vincent, A., J. McConville, M.E. Farrugia & J. Newsom-Davis. 2004. Seronegative myasthenia gravis. Semin. Neurol. 24 : 125 133.
10. Evoli, A., M.R. Bianchi, R. Riso, et al. 2008. Response to therapy in myasthenia gravis with anti-MuSK antibodies. Ann. N.Y. Acad Sci. Myasthenia Gravis and Related Disorders: 11th International Conference. In Press.
11. Farrugia, M.E., R.P. Kennett, J. Newsom-Davis, et al. 2006. Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis. Muscle Nerve 33 : 568 570.
12. Nemoto, Y., S. Kuwabara, S. Misawa, et al. 2005. Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J. Neurol. Neurosurg. Psychiatry 76 : 714 718.
13. Leite, M.I., P. Strobel, M. Jones, et al. 2005. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann. Neurol. 57 : 444 448.
14. Leite, M.I., M. Jones, P. Ströbel, et al. 2007. Myasthenia gravis thymus: complement vulnerabiltiy of epithelial and myoid cells, complement attack on them, and its correlation with autoantibody status. Am. J. Pathol. 171 : 893 905.
15. Willcox, N., M.I. Leite, Y. Kadota, et al. 2008. Autoimmunizing mechanisms in thymoma and thymus. Ann. N.Y. Acad Sci. Myasthenia Gravis and Related Disorders: 11th International Conference. In Press.
16. Lauriola, L., F. Ranelletti, N. Maggiano, et al. 2005. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 64 : 536 538.
17. Farrugia, M.E., M.D. Robson, L. Clover, et al. 2006. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain 129 : 1481 1492.
18. Farrugia, M.E., R.P. Kennett, D. Hilton-Jones, et al. 2007. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies. Clin. Neurophysiol. 118 : 269 277.
19. McConville, J., M.E. Farrugia, D. Beeson, et al. 2004. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann. Neurol. 55 : 580 584.
20. Blaes, F., D. Beeson, P. Plested, et al. 2000. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor. Ann. Neurol. 47 : 504 510.
21. Selcen, D., T. Fukuda, X.M. Shen & A.G. Engel. 2004. Are MuSK antibodies the primary cause of myasthenic symptoms? Neurology 62 : 1945 1950.
22. Mossman, S., A. Vincent & J. Newsom-Davis. 1986. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet 1 : 116 119.
23. Burges, J., A. Vincent, P.C. Molenaar, et al. 1994. Passive transfer of seronegative myasthenia gravis to mice. Muscle Nerve 17 : 1393 1400.
24. Vincent, A. & M.I. Leite. 2005. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr. Opin. Neurol. 18 : 519 525.
25. Hoch, W., J. McConville, S. Helms, et al. 2001. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7 : 365 368.
26. Farrugia, M.E., D.M. Bonifati, L. Clover, et al. 2007. Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures. J. Neuroimmunol. 185 : 136 144.
27. Benveniste, O., L. Jacobson, M.E. Farrugia, et al. 2005. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo. J. Neuroimmunol. 170 : 41 48.
28. Bodine, S.C., E. Latres, S. Baumhueter, et al. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294 : 1704 1708.
29. Boneva, N., M. Frenkian-Cuvelier, J. Bidault, et al. 2006. Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis. J. Neuroimmunol. 177 : 119 131.
30. Jha, S., K. Xu, T. Maruta, et al. 2006. Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK). J. Neuroimmunol. 175 : 107 117.
31. Shigemoto, K., S. Kubo, N. Maruyama, et al. 2006. Induction of myasthenia by immunization against muscle-specific kinase. J. Clin. Invest. 116 : 1016 1024.
32. Shigemoto, S.K., C. Jie, N. Hato, et al. 2008. Myasthenia gravis experimentally induced with muscle-specific kinase. Ann. N.Y. Acad. Sci. Myasthenia Gravis and Related Disorders: 11th International Conference. In Press.
33. Balasa, B., C. Deng, J. Lee, et al. 1998. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis. J. Immunol. 161 : 2856 2862.
34. Giraud, M., Taubert, R., C. Vandiedonck, et al. 2007. An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature 448 : 934 937.
35. Kyewski, B. & R. Taubert. 2008. How Promiscuity promotes tolerance: the case of myasthenia gravis. Ann. N.Y. Acad. Sci. Myasthenia and Related Disorders: 11th International Conference. In Press.
36. Spreadbury, I., U. Kishore, D. Beeson & A. Vincent. 2005. Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation. J. Neuroimmunol. 162 : 149 156.
37. Jermy, A., D. Beeson & A. Vincent. 1993. Pathogenic autoimmunity to affinity-purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice. Eur.J. Immunol. 23 : 973 976.